The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitors

Описание к видео The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitors

Earn CME for related activities: https://www.naccme.com/oln

In this presentation from the Lymphoma & Myeloma 2017, Dr. Adam D. Cohen discusses the future of multiple myeloma therapy, with a specific focus on BITE immunotherapy, CAR-T, and immune checkpoint inhibitors.

© 2017 Imedex, LLC.

Комментарии

Информация по комментариям в разработке